Read + Share
Galan-Gutierrez M, Font-Ugalde P, Padilla L, Hernandez-Montoya C, et al. Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real
clinical practice in Andalucia, Spain. Int J Dermatol 2023;62:700-706.
PMID: 36495585
|
 |
|
Galan-Gutierrez M, Font-Ugalde P, Padilla L, Hernandez-Montoya C, et al. Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real
clinical practice in Andalucia, Spain. Int J Dermatol 2023;62:700-706.
PMID: 36495585
|
|
|
|